BILL · Investment summary · as of 12 August 2026
Priced close to what the business has demonstrated
Business type: Inflection · scaling but economically observable
The business does not meet the quality standard for its economic type.
At $48.70, BILL requires a 7% five-year revenue growth rate to justify its enterprise value — less than the business already delivers, at 12%.
The conditions that would settle the disagreement are dated to August 2026.
The value rests on an exit multiple of 15.9x, a terminal operating margin of 12% and a 8.0% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | Not determined — the operating driver is not stated in one place |
| What do we forecast? | Revenue growth of 12% demonstrated; a terminal operating margin of 12%; an exit multiple of 15.9x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is +5.4 percentage points. |
| What is it worth? | Twelve-month target $58.10, +19% from the struck price. Scenario-weighted expected return net of costs +19.3%. |
| Why now? | The first dated test of the thesis falls on 19 August 2026. |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| 19 August 2026 | Next scheduled results | Revenue and margin in line with, or above, the house path | A miss that moves the full-year path below the guided floor |
| 19 August 2026 | Core (subscription + transaction) revenue growth, FY2027 guidance | FY2027 core revenue growth guided at or above 12% | FY2027 core revenue growth guided below 12% |
| each quarterly release | Transaction fees / TPV | Neither leg of the condition opposite is met at this date | Take rate declines in two consecutive quarters |
| FY2026 10-K, expected late Aug 2026 | NDR, annual disclosure | FY2026 net dollar-based retention at or above 92% | FY2026 net dollar-based retention below 92% |
Not determined — no permanent-loss case with a named cause is on file; a bear valuation is not an impairment case
Estimated probability 10%, against the 24% level at which the position would be resized. It sits within that level.
Falsifiable and fundamental — not one of them is a price condition.
On approach to the $58.10 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Not met | Is the business worth owning under its declared economic type? |
| Valuation | Met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Not determined | What is the realistic permanent-loss case? Not established on the evidence on file. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Met | Is there a dated event that resolves the disagreement? |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The strongest case for mispricing is that the business already delivers +5.4 percentage points more growth than the price requires. The most important unresolved uncertainty is whether the operating record is long enough to constrain the terminal value at all. The next evidence that should change the portfolio decision is the test dated 19 August 2026, or a daily close below $42.67, which forces an immediate review.